Form 4: Amarin Director Paul Cohen Reports RSU Vesting
Statement of Changes in Beneficial Ownership
Director Paul Cohen acquired 838 American Depositary Shares through the vesting of restricted stock units.
Summary
- Director Paul Cohen acquired 838 American Depositary Shares (ADS) on April 18, 2026, following the vesting of restricted stock units (RSUs).
- A total of 403 shares were withheld by the company to satisfy tax obligations related to the vesting, resulting in a net increase in beneficial ownership.
- The transaction reflects the vesting of the second installment of an RSU grant originally awarded on April 18, 2024.
- The reporting reflects adjustments made for the company's ADS ratio change implemented on April 11, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative event related to executive compensation, having no material impact on the company's operational outlook.
Positives
- Director maintains a direct beneficial ownership of 836 American Depositary Shares following the transaction.
- The transaction was a routine vesting event rather than a discretionary market sale.
Negatives
- The company withheld 403 shares to cover tax liabilities, which is a standard but non-cash-generating event for the director.
Risks
- The company is subject to ongoing volatility in the pharmaceutical sector and potential regulatory challenges regarding its product portfolio.
Future Outlook
The remaining RSU installment is scheduled to vest on April 18, 2027, subject to continued service.
Management Comments
- The filing notes that the tax withholding was incident to the vesting of a security and not a market sale of securities.
Industry Context
StockSavvy.ai notes that routine RSU vesting for directors is a standard corporate governance practice in the biotechnology sector, typically signaling long-term alignment rather than immediate market sentiment.
Comparison to Industry Standards
- The use of RSU vesting schedules is consistent with standard executive compensation practices among mid-cap pharmaceutical companies.
- Tax withholding at vesting is a standard regulatory compliance procedure for equity-based compensation.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine equity compensation event.
Next Steps
- Final RSU vesting installment scheduled for April 18, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Original grant date of the Restricted Stock Units. |
| 04/11/2025 | Effective date of the ADS Ratio Change. |
| 04/18/2026 | Date of the reported RSU vesting and tax withholding transaction. |
Keywords
Amarin, AMRN, Form 4, Insider Trading, Director, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.